B-type natriuretic peptide in rheumatic diseases: A cardiac biomarker or a sophisticated acute phase reactant?
Authors:
- Theodoros DimitroulasTDTheodoros Dimitroulas
- George GiannakoulasGGGeorge Giannakoulas
- Haralambos KarvounisHKHaralambos Karvounis
- Alexandros GaryfallosAGAlexandros Garyfallos
- Lukas SettasLSLukas Settas
- George KitasGKGeorge Kitas
- 1 October 2012
- journal article
- review article
- Published by Elsevier in Autoimmunity Reviews
- Vol. 11 (12) , 837-843
Abstract
No abstract availableKeywords
This publication has 72 references indexed in Scilit:
- Interpretation and Use of Natriuretic Peptides in Non-Congestive Heart Failure SettingsYonsei Medical Journal, 2010
- Natriuretic Peptides in the Diagnosis and Management of Chronic Heart FailureHeart Failure Clinics, 2009
- Natriuretic peptides in elderly people with acute myocardial infarctionBMJ, 2009
- Changes in causes of death in systemic sclerosis, 1972–2002Annals of the Rheumatic Diseases, 2007
- Excess recurrent cardiac events in rheumatoid arthritis patients with acute coronary syndromeAnnals of the Rheumatic Diseases, 2006
- Plasma Natriuretic Peptide Levels and the Risk of Cardiovascular Events and DeathNew England Journal of Medicine, 2004
- B-type natriuretic peptide in cardiovascular diseaseThe Lancet, 2003
- Interaction of Myocytes and Nonmyocytes Is Necessary for Mechanical Stretch to Induce ANP/BNP Production in Cardiocyte CultureJournal of Cardiovascular Pharmacology, 1998
- Pulmonary hypertension in systemic sclerosis: an analysis of 17 patientsRheumatology, 1996
- A rapid and potent natriuretic response to intravenous injection of atrial myocardial extract in ratsLife Sciences, 1981